GAPDH and Alzheimer disease: In fact, the blood S-glutathionylated GAPDH levels of these clinical controls were still lower than those of the 39 patients with AD aged 70–89 years who were recruited from the Outpatient Neurology Clinic (728.7 ± 304.7 ng/dL) (p < 0.001) (Fig 3).